Latest Breaking News On - Heather kinkead - Page 1 : vimarsana.com

/PRNewswire/ Inhibrx, Inc. (Nasdaq: INBX), a biotechnology company with four clinical programs in development and an emerging pre-clinical pipeline,.

United statesHeather kinkeadKatelynm willisBrendan eckelmanBristol myers squibbPrnewswire inhibrx incAmerican association for cancer researchInhibrx incCancer researchAnnual meetingNew orleansInhibrx co founderChief scientificExhibit hallsPoster sectionMedia contact